UBS Group’s Jaguar Health JAGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12K | Buy |
267
+52
| +24% | +$5.02K | ﹤0.01% | 8470 |
|
|
2026
Q1 | $41.8K | Buy |
215
+203
| +1,692% | +$71.5K | ﹤0.01% | 7489 |
|
|
2025
Q4 | $5.95K | Buy |
+12
| New | +$10.2K | ﹤0.01% | 8605 |
|
|
2025
Q3 | – | Sell |
-21
| Closed | -$23.5K | – | 10259 |
|
|
2025
Q2 | $28.2K | Buy |
21
+13
| +163% | +$39.1K | ﹤0.01% | 8207 |
|
|
2025
Q1 | $20.5K | Buy |
8
+4
| +100% | +$37.3K | ﹤0.01% | 8212 |
|
|
2024
Q4 | $51.2K | Buy |
4
+1
| +33% | +$14.1K | ﹤0.01% | 7275 |
|
|
2024
Q3 | $45.6K | Buy |
+3
| New | +$71.8K | ﹤0.01% | 6883 |
|
|
2024
Q2 | – | Hold |
0
| – | -$3.92K | – | 9792 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 7681 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7775 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 8622 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 8685 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7904 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 8477 |
|
|
2022
Q3 | – | Hold |
0
| – | -$11K | – | 10627 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7814 |
|
|
2021
Q2 | – | Hold |
0
| – | -$17K | – | 9587 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7518 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 8006 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5969 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6789 |
|
|
2019
Q1 | – | Hold |
0
| – | -$13K | – | 7927 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7093 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7571 |
|
|
2018
Q1 | – | Hold |
0
| – | -$4K | – | 7994 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 7468 |
|
|
2017
Q3 | – | Hold |
0
| – | -$11K | – | 7859 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6711 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6747 |
|
|
2016
Q4 | – | Hold |
0
| – | -$7K | – | 7895 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6979 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6897 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6923 |
|
|
2015
Q4 | – | Hold |
0
| – | -$15K | – | 8459 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6962 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 7696 |
|
Other funds holding JAGX
IAIM
UBS Group's JAGX Position: Q2 2026 in Review
UBS Group increased its Jaguar Health (JAGX) stake by 24% in Q2 2026, buying an estimated $5.02K and bringing the position to 267 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #8470.
UBS Group first reported a position in JAGX in Q3 2024 and has held it in 7 quarters since. The position peaked at $51.2K in Q4 2024. 5 funds tracked by Wall St. Rank hold JAGX as of Q2 2026.
- UBS Group held 267 shares of Jaguar Health worth $12K as of Q2 2026.
- UBS Group bought 52 Jaguar Health shares in Q2 2026, an estimated $5.02K.
- Jaguar Health made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8470 holding.
- UBS Group first reported a position in Jaguar Health in Q3 2024 and has held it in 7 quarters since.
- UBS Group's Jaguar Health position peaked at $51.2K in Q4 2024.
- 5 funds tracked by Wall St. Rank held Jaguar Health as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.